{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:48:33Z","timestamp":1792136913704,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jiph.2026.103379","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:20:02Z","timestamp":1790781602000},"page":"103379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monkeypox as an emerging public health concern: Evidence gaps, translational barriers, transmission, risk factors, and prevention strategies"],"prefix":"10.1016","volume":"19","author":[{"given":"Nahla Sameh","family":"Tolba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.H.","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-249X","authenticated-orcid":false,"given":"Emad M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman A.","family":"Alsalamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa S.","family":"Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jiph.2026.103379_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104486","article-title":"Challenges of broad-spectrum antiviral drug discovery and development for emerging pathogens","volume":"30","author":"Martin","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jiph.2026.103379_bib2","article-title":"Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach","volume":"13","author":"Akash","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiph.2026.103379_bib3","unstructured":"WHO. Multi-country outbreak of mpox: External situation report No. 62, 23 January 2026. Geneva: World Health Organization. 2026;62(23):https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/emergencies\/multi-country-outbreak-of-mpox--external-situation-report_62.pdf?download=true&sfvrsn=3a355eb6_3."},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/futurepharmacol5040069","article-title":"Natural Product-Based Drug Discovery for Monkeypox Virus: Integrating In Silico Approaches and Therapeutic Development Strategies","volume":"5","author":"Mushebenge","year":"2025","journal-title":"Future Pharmacol"},{"issue":"10370","key":"10.1016\/j.jiph.2026.103379_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2026.103379_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2024.100141","article-title":"Unveiling the global surge of mpox (monkeypox): a comprehensive review of current evidence","author":"Duarte","year":"2024","journal-title":"Microbe"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fvl.12.130","article-title":"A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012","volume":"8","author":"Parker","year":"2013","journal-title":"Future Virol"},{"key":"10.1016\/j.jiph.2026.103379_bib8","doi-asserted-by":"crossref","unstructured":"Ola P. The origin of the mysterious multi-country monkeypox outbreak in non-endemic countries. 2022.","DOI":"10.22541\/au.165426607.74780750\/v1"},{"issue":"7","key":"10.1016\/j.jiph.2026.103379_bib9","article-title":"Learning from the past: the history of human monkeypox and the atypical multi-country outbreak in 2022","volume":"24","author":"Kai-Hu","year":"2022","journal-title":"Chin J Contemp Pediatr"},{"issue":"33","key":"10.1016\/j.jiph.2026.103379_bib10","first-page":"240815v","article-title":"Note from the editors: WHO declares mpox outbreak a public health emergency of international concern","volume":"29","author":"Team","year":"2024","journal-title":"Eurosurveillance"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12088-024-01244-3","article-title":"Inhibition of Monkeypox Virus DNA Polymerase Using Moringa oleifera Phytochemicals: Computational Studies of Drug-Likeness, Molecular Docking, Molecular Dynamics Simulation and Density Functional Theory","volume":"64","author":"Yousaf","year":"2024","journal-title":"Indian J Microbiol"},{"issue":"22","key":"10.1016\/j.jiph.2026.103379_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27227718","article-title":"Identification of Antiviral Compounds against Monkeypox Virus Profilin-like Protein A42R from Plantago lanceolata","volume":"27","author":"Bajrai","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jiph.2026.103379_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/a-2560-1844","article-title":"Natural Compounds against Mpox: Mapping Evidence and Identifying Gaps","volume":"91","author":"Sharifan","year":"2025","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-025-00603-3","article-title":"Plant-derived molecules in monkeypox management: insight and alternative therapeutic strategies","volume":"14","author":"Ndayambaje","year":"2025","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42739","article-title":"Nanoparticles of natural product-derived medicines: Beyond the pandemic","volume":"11","author":"Herdiana","year":"2025","journal-title":"Heliyon"},{"issue":"08","key":"10.1016\/j.jiph.2026.103379_bib16","article-title":"Identification of antiviral drug candidates against monkeypox DNA polymerase and profilin-like protein A42R utilizing an in-silico approach","volume":"2024","author":"Amjid","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020171","article-title":"Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers","volume":"12","author":"Cojocaru","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib18","article-title":"Emerging threats of monkeypox virus in 2024: current insights and future directions","volume":"11","author":"L SD","year":"2025","journal-title":"Future Sci OA"},{"key":"10.1016\/j.jiph.2026.103379_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102317","article-title":"Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease","volume":"16","author":"Touhtouh","year":"2025","journal-title":"Results Chem"},{"key":"10.1016\/j.jiph.2026.103379_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2025.1637207","article-title":"Computational investigation of potential natural compounds as inhibitors of monkeypox virus cysteine proteinase","volume":"5","author":"Nalwa","year":"2025","journal-title":"Front Bioinforma"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","article-title":"Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"145","author":"Chang","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jep.2013.04.040","article-title":"Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"148","author":"Feng Yeh","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tim.2011.12.001","article-title":"Outbreaks of human monkeypox after cessation of smallpox vaccination","volume":"20","author":"Reynolds","year":"2012","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J Infect Public Health"},{"issue":"10","key":"10.1016\/j.jiph.2026.103379_bib27","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41591-023-02542-x","article-title":"Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal","volume":"29","author":"Borges","year":"2023","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.jiph.2026.103379_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1603","article-title":"Molecular epidemiology, transmission and clinical features of 2022-mpox outbreak: a systematic review","volume":"6","author":"Sharif","year":"2023","journal-title":"Health Sci Rep"},{"issue":"12","key":"10.1016\/j.jiph.2026.103379_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cmi.2023.09.004","article-title":"Clinical review of human mpox","volume":"29","author":"Ogoina","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"19","key":"10.1016\/j.jiph.2026.103379_bib30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jiph.2026.103379_bib31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jiph.2026.103379_bib32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S1473-3099(23)00427-9","article-title":"Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study","volume":"23","author":"Ogoina","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.jiph.2026.103379_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies","volume":"332","author":"Titanji","year":"2024","journal-title":"Jama"},{"issue":"6615","key":"10.1016\/j.jiph.2026.103379_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.add4507","article-title":"Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022","volume":"378","author":"Endo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jiph.2026.103379_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2024.101487","article-title":"The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era","volume":"62","author":"Singh","year":"2024","journal-title":"New Microbes New Infect"},{"issue":"20","key":"10.1016\/j.jiph.2026.103379_bib36","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2023.04.010","article-title":"Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies","volume":"41","author":"Roper","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14010001","article-title":"Comprehensive Insights into Monkeypox (mpox): Recent Advances in Epidemiology, Diagnostic Approaches and Therapeutic Strategies","volume":"14","author":"Kumar","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib38","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4102\/ajlm.v14i1.2644","article-title":"Mpox: An emerging or re-emerging infection with a potential colossal burden on healthcare globally","volume":"14","author":"Obi","year":"2025","journal-title":"Afr J Lab Med"},{"issue":"12","key":"10.1016\/j.jiph.2026.103379_bib39","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1080\/07391102.2023.2231542","article-title":"A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus","volume":"42","author":"Hossain","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2026.103379_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1654467","article-title":"Evaluating the advancements and efficacies in pharmacological Mpox treatments: a comprehensive review","volume":"16","author":"Hudu","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiph.2026.103379_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2021.102094","article-title":"Traditional medicinal plants used for treating emerging and re-emerging viral diseases in northern Nigeria","volume":"49","author":"Abubakar","year":"2022","journal-title":"Eur J Integr Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-022-01751-z","article-title":"Searching for plant-derived antivirals against dengue virus and Zika virus","volume":"19","author":"de Castro Barbosa","year":"2022","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.jiph.2026.103379_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/03639045.2024.2431934","article-title":"Eco-friendly synthesis of silver nanoparticles by Trigonella foenum-graecum: formulations, characterizations, and application in wound healing","volume":"50","author":"Al-Subaiyel","year":"2024","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.jiph.2026.103379_bib44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.5455\/OVJ.2024.v14.i5.23","article-title":"Can silver nanoparticles stabilized by Fenugreek (Trigonella foenm -graecum) improve tibial bone defects repair in rabbits? A preliminary study","volume":"14","author":"Sadan","year":"2024","journal-title":"Open Vet J"},{"issue":"15","key":"10.1016\/j.jiph.2026.103379_bib45","first-page":"5529","article-title":"Green synthesis of silver nanoparticles reduced with Trigonella foenum-graecum and their effect on tumor necrosis factor-alpha in MCF7 cells","volume":"26","author":"Abdellatif","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jiph.2026.103379_bib46","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.22207\/JPAM.16.SPL1.04","article-title":"Computational purposing phytochemicals against cysteine protease of Monkeypox virus: an in-silico approach","volume":"16","author":"Bansal","year":"2022","journal-title":"Pure Appl Microbiol"},{"issue":"5","key":"10.1016\/j.jiph.2026.103379_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jtcme.2023.04.002","article-title":"Computational studies on searching potential phytochemicals against DNA polymerase activity of the monkeypox virus","volume":"13","author":"Vardhan","year":"2023","journal-title":"J Tradit Complement Med"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jobb.2024.05.004","article-title":"Structure-based discovery of F. religiosa phytochemicals as potential inhibitors against Monkeypox (mpox) viral protein","volume":"6","author":"Mohapatra","year":"2024","journal-title":"J Biosaf Biosecurity"},{"key":"10.1016\/j.jiph.2026.103379_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1073419","article-title":"Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation","volume":"13","author":"Gulati","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2026.103379_bib50","article-title":"Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach","volume":"43","author":"Pourhajibagher","year":"2023","journal-title":"Photo Photodyn Ther"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.17798\/bitlisfen.1388403","article-title":"silico Evaluation of the Potential of Natural Products from Chili Pepper as Antiviral Agents Against Dna-Directed Rna Polymerase of the Monkeypox Virus","volume":"13","author":"Fidan","year":"2024","journal-title":"Bitlis Eren \u00dcniversitesi Fen Bilim Derg"},{"key":"10.1016\/j.jiph.2026.103379_bib52","first-page":"1","article-title":"silico analysis of identified molecules using LC\u2013HR\/MS of Cupressus sempervirens L. ethyl acetate fraction against three monkeypox virus targets","author":"Linani","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2026.103379_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1445606","article-title":"Salsoline derivatives, genistein, semisynthetic derivative of kojic acid, and naringenin as inhibitors of A42R profilin-like protein of monkeypox virus: in silico studies","volume":"12","author":"Chebaibi","year":"2024","journal-title":"Front Chem"},{"issue":"12","key":"10.1016\/j.jiph.2026.103379_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01536-24","article-title":"Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein","volume":"98","author":"Xiong","year":"2024","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.jiph.2026.103379_bib55","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.3390\/molecules27227718","article-title":"\"Identification of antiviral compounds against monkeypox virus profilin-like protein A42R from Plantago lanceolata","volume":"27","author":"Bajrai","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12088-024-01244-3","article-title":"\"Inhibition of monkeypox virus DNA polymerase using Moringa oleifera phytochemicals: computational studies of drug-likeness, molecular docking, molecular dynamics simulation and density functional theory","volume":"64","author":"Yousaf","year":"2024","journal-title":"Indian J Microbiol"},{"issue":"12","key":"10.1016\/j.jiph.2026.103379_bib57","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1080\/07391102.2023.2231542","article-title":"A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus","volume":"42","author":"Hossain","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.17798\/bitlisfen.1388403","article-title":"silico Evaluation of the Potential of Natural Products from Chili Pepper as Antiviral Agents Against Dna-Directed Rna Polymerase of the Monkeypox Virus","volume":"13","author":"Fidan","year":"2024","journal-title":"Bitlis Eren \u00dcniversitesi Fen Bilim Derg"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1568005053174627","article-title":"Orthopoxvirus Targets for the Development of Antiviral Therapies","volume":"5","author":"Prichard","year":"2005","journal-title":"Curr Drug Target -Infect Disord"},{"issue":"05","key":"10.1016\/j.jiph.2026.103379_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/a-2560-1844","article-title":"Natural Compounds against Mpox: Mapping Evidence and Identifying Gaps","volume":"91","author":"Sharifan","year":"2025","journal-title":"Planta Med"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04745-22","article-title":"Identification of In Vitro Inhibitors of Monkeypox Replication","volume":"11","author":"Chiem","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"20","key":"10.1016\/j.jiph.2026.103379_bib62","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2023.04.010","article-title":"Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies","volume":"41","author":"Roper","year":"2023","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jiph.2026.103379_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100345","article-title":"Dall'Acqua S. The Influence of Environmental Conditions on Secondary Metabolites in Medicinal Plants: A Literature Review","volume":"18","author":"Pant","year":"2021","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jiph.2026.103379_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2021.100070","article-title":"Quality control of herbal drugs and preparations: The methods of analysis, their relevance and applications","volume":"4","author":"Muyumba","year":"2021","journal-title":"Talanta Open"},{"issue":"6","key":"10.1016\/j.jiph.2026.103379_bib65","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/C9NP00011A","article-title":"Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2","volume":"36","author":"Caesar","year":"2019","journal-title":"Nat Product Rep"},{"issue":"8","key":"10.1016\/j.jiph.2026.103379_bib66","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1039\/C8NP00065D","article-title":"Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach","volume":"36","author":"Kellogg","year":"2019","journal-title":"Nat Product Rep"},{"key":"10.1016\/j.jiph.2026.103379_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104647","article-title":"Regulatory landscape of dietary supplements and herbal medicines from a global perspective","volume":"114","author":"Thakkar","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"issue":"10","key":"10.1016\/j.jiph.2026.103379_bib68","article-title":"Biosynthesis of Copper Nanoparticles with Medicinal Plants Extracts: From Extraction Methods to Applications","volume":"14","author":"Antonio-Perez","year":"2023","journal-title":"Micro (Basel)"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/nano10030455","article-title":"Nanopharmaceutics: Part II-Production Scales and Clinically Compliant Production Methods","volume":"10","author":"Souto","year":"2020","journal-title":"Nanomater (Basel)"},{"key":"10.1016\/j.jiph.2026.103379_bib70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2018.06.024","article-title":"Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?","volume":"131","author":"Muhlebach","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/157016305775202937","article-title":"Nature's medicines: traditional knowledge and intellectual property management. Case studies from the National Institutes of Health (NIH), USA","volume":"2","author":"Gupta","year":"2005","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.jiph.2026.103379_bib72","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodriguez-Gomez","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jiph.2026.103379_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2024.100478","article-title":"Pharmacological update on Benincasa hispida (Thunb.): A review","author":"Singh","year":"2024","journal-title":"Pharmacol Res-Mod Chin Med"},{"key":"10.1016\/j.jiph.2026.103379_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.102211","article-title":"Phyto-pharmacological wonders of genus Ficus: Ethnopharmacological insights and phytochemical treasures from natural products","author":"Hasnat","year":"2024","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jiph.2026.103379_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2025.106415","article-title":"Schisandraceae family fruits: Exploring chemophenetic significance, UPLC\/MSn database, phytochemistry, and pharmacological potential","author":"Kemayou","year":"2025","journal-title":"Fitoterapia"},{"issue":"9","key":"10.1016\/j.jiph.2026.103379_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092055","article-title":"Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics","volume":"10","author":"Bhalani","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.jiph.2026.103379_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jiph.2026.103379_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2016.07.008","article-title":"Nano-formulations of drugs: Recent developments, impact and challenges","volume":"128-129","author":"Jeevanandam","year":"2016","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib79","doi-asserted-by":"crossref","DOI":"10.17582\/journal.aavs\/2020\/8.4.433.443","article-title":"Evaluations of Potential Antiviral Effects of Green Zinc Oxide and Silver Nanoparticles against Bovine Herpesvirus-1","volume":"8","author":"Zeedan","year":"2020","journal-title":"Adv Anim Vet Sci"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib80","article-title":"Nanomedicine as a Potential Tool against Monkeypox","volume":"11","author":"Mohamed","year":"2023","journal-title":"Vaccin (Basel)"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib81","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/09603123.2020.1789946","article-title":"Antiviral activity of algae biosynthesized silver and gold nanoparticles against Herps Simplex (HSV-1) virus in vitro using cell-line culture technique","volume":"32","author":"El-Sheekh","year":"2020","journal-title":"Int J Environ Health Res"},{"key":"10.1016\/j.jiph.2026.103379_bib82","doi-asserted-by":"crossref","unstructured":"Abdelaaliem F.R. Green Synthesized Nanoparticles for Treatment of Human Viruses: Recent Advances and Future Prospective. 2023.doi:10.2139\/ssrn.4471836.","DOI":"10.2139\/ssrn.4471836"},{"key":"10.1016\/j.jiph.2026.103379_bib83","first-page":"561","article-title":"Japanese encephalitis virus infection","author":"Griffiths","year":"2014","journal-title":"Neurovirology Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib84","article-title":"Green Synthesis of Phytochemical Nanoparticles and their Antimicrobial Activity, A Review Study","volume":"34","author":"Islam","year":"2021","journal-title":"Biomed J Sci & Tech Res"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7150\/ntno.19796","article-title":"Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation","volume":"1","author":"Chattopadhyay","year":"2017","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.jiph.2026.103379_bib86","first-page":"29","article-title":"Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles","volume":"433","author":"Grego","year":"2021","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.jiph.2026.103379_bib87","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s12011-020-02414-2","article-title":"Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections","volume":"199","author":"Maduray","year":"2021","journal-title":"Biol Trace Elem Res"},{"issue":"716","key":"10.1016\/j.jiph.2026.103379_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11671-008-9128-2","article-title":"A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation","volume":"3","author":"Rogers","year":"2008","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.jiph.2026.103379_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105668","article-title":"Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice","volume":"216","author":"Xia","year":"2023","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiph.2026.103379_bib91","unstructured":"Kayesth S., Chaudhary A., Shazad M., Saini P., Nisspatorn V., Shah V.K., et al. Plant metabolites as potential therapeutics against COVID-19 and other viral diseases. 2024."},{"key":"10.1016\/j.jiph.2026.103379_bib92","first-page":"327","article-title":"Green Synthesis of Reduced Graphene Oxide, Carbon Dots, and Its Composites for Infectious Diseases","author":"Gedda","year":"2025","journal-title":"Sustain Nanomater Treat Diagn Infect Dis"},{"key":"10.1016\/j.jiph.2026.103379_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1391345","article-title":"Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology","volume":"15","author":"Sharma","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2026.103379_bib94","unstructured":"CANBAZ G.T. APPLICATIONS OF MEDICINAL AND AROMATIC PLANTS IN NANOTECHNOLOGY. DIFFERENT PERSPECTIVES IN MEDICINAL AND AROMATIC PLANTS.309, 2025."},{"key":"10.1016\/j.jiph.2026.103379_bib95","unstructured":"Arshad J., Ilyas K., Iqbal H., Aslam M.A., Saboor A., Naeem H. Botanical Therapy as an Anticancer Mode of Treatment. Complementary and Alternative Medicine: Chinese.132."},{"issue":"7","key":"10.1016\/j.jiph.2026.103379_bib96","article-title":"Effects of plant metabolites on the growth of COVID-19 (Coronavirus Disease-19) including omicron strain","volume":"14","author":"Bagde","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jiph.2026.103379_bib97","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1016\/j.ygeno.2020.07.033","article-title":"Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2","volume":"112","author":"Sharma","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.jiph.2026.103379_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fntpr.2024.1470639","article-title":"Boosting the human antiviral response in conjunction with natural plant products","volume":"3","author":"Srivastava","year":"2025","journal-title":"Front Nat Prod"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib99","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/v16020218","article-title":"Medicinal Plants against Viral Infections: A Review of Metabolomics Evidence for the Antiviral Properties and Potentials in Plant Sources","volume":"16","author":"Adeosun","year":"2024","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.jiph.2026.103379_bib100","article-title":"Medicinal Plants as Effective Antiviral Agents and Their Potential Benefits","volume":"19","author":"Atampugbire","year":"2024","journal-title":"Nat Product Commun"},{"key":"10.1016\/j.jiph.2026.103379_bib101","first-page":"1","article-title":"Nanoformulations in the treatment of lung cancer: current status and clinical potential","author":"Younis","year":"2024","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12249-024-02734-9","article-title":"Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer","volume":"25","author":"Abdellatif","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jiph.2026.103379_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100500","article-title":"Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy","volume":"19","author":"Bouazzaoui","year":"2024","journal-title":"Vaccin X"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020140","article-title":"Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants","volume":"13","author":"Bouazzaoui","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jiph.2026.103379_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.113111","article-title":"Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine","volume":"222","author":"Abdellatif","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib106","article-title":"Recent Developments in Mpox Prevention and Treatment Options","volume":"11","author":"Malik","year":"2023","journal-title":"Vaccin (Basel)"},{"issue":"10","key":"10.1016\/j.jiph.2026.103379_bib107","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1039\/D2BM02066A","article-title":"Advances in nanomedicine for the treatment of infectious diseases caused by viruses","volume":"11","author":"Dash","year":"2023","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12249-020-01908-5","article-title":"Recent advancement in nanotechnology-based drug delivery system against viral infections","volume":"22","author":"Pradhan","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib109","doi-asserted-by":"crossref","DOI":"10.4081\/idr.2011.2370","article-title":"Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants","volume":"3","author":"Eszterhas","year":"2011","journal-title":"Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.jiph.2026.103379_bib110","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/acsabm.2c00034","article-title":"Preparation, characterization, and antimicrobial and antiviral properties of silver-containing nanocomposites based on polylactic acid-chitosan","volume":"5","author":"Demchenko","year":"2022","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib111","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2356153","article-title":"Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study","volume":"13","author":"Li","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jiph.2026.103379_bib112","article-title":"Africa and monkeypox vaccinations: A call for action","volume":"49","author":"Farahat","year":"2022","journal-title":"New Microbes New Infect"},{"issue":"9","key":"10.1016\/j.jiph.2026.103379_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30092004","article-title":"Silver Nanoparticles (AgNPs) as Potential Antiviral Agents: Synthesis, Biophysical Properties, Safety, Challenges and Future Directions horizontal line Update Review","volume":"30","author":"Sati","year":"2025","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11030629","article-title":"Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications","volume":"11","author":"Luceri","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiph.2026.103379_bib115","first-page":"1331","article-title":"Synthesis, role in antibacterial, antiviral, and hazardous effects of silver nanoparticles","volume":"2","author":"Saadh","year":"2021","journal-title":"Pharmacologyonline"},{"key":"10.1016\/j.jiph.2026.103379_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2022.1064615","article-title":"Nano-antivirals: A comprehensive review","volume":"4","author":"Hussain","year":"2022","journal-title":"Front Nanotechnol"},{"issue":"10","key":"10.1016\/j.jiph.2026.103379_bib117","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.3390\/molecules16108894","article-title":"Silver nanoparticles as potential antiviral agents","volume":"16","author":"Galdiero","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jiph.2026.103379_bib118","article-title":"Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems","volume":"63","author":"Abdellatif","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jiph.2026.103379_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1056385","article-title":"Acute hepatitis of unknown origin in children: A combination of factors","volume":"13","author":"Gong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"18","key":"10.1016\/j.jiph.2026.103379_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/nano14181527","article-title":"Silver Nanoparticles: A Comprehensive Review of Synthesis Methods and Chemical and Physical Properties","volume":"14","author":"Duman","year":"2024","journal-title":"Nanomater (Basel)"},{"key":"10.1016\/j.jiph.2026.103379_bib121","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jff.2014.07.012","article-title":"Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food \u2013 a review","volume":"18","author":"Sidor","year":"2015","journal-title":"J Funct Foods"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib122","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jep.2013.04.040","article-title":"Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"148","author":"Feng Yeh","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"10.1016\/j.jiph.2026.103379_bib123","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/13880200500408491","article-title":"Characterization of Antiviral Activities inEchinacea. Root Preparations","volume":"43","author":"Hudson","year":"2008","journal-title":"Pharm Biol"},{"issue":"5","key":"10.1016\/j.jiph.2026.103379_bib124","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jam.12453","article-title":"Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus","volume":"116","author":"Gilling","year":"2014","journal-title":"J Appl Microbiol"},{"issue":"24","key":"10.1016\/j.jiph.2026.103379_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415941","article-title":"Pharmacological Agents with Antiviral Activity against Monkeypox Infection","volume":"23","author":"Zovi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/compounds2030017","article-title":"Ethnomedicinal, Phytochemistry and Antiviral Potential of Turmeric (Curcuma longa)","volume":"2","author":"Srivastava","year":"2022","journal-title":"Compounds"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1286-4579(99)80003-3","article-title":"Antimicrobial properties of allicin from garlic","volume":"1","author":"Ankri","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jiph.2026.103379_bib128","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2019.06.005","article-title":"The development and approval of tecoviromat (TPOXX\u00ae), the first antiviral against smallpox","volume":"168","author":"Merchlinsky","year":"2019","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2020","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.jiph.2026.103379_bib130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.10.012","article-title":"Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia","volume":"114","author":"Andrei","year":"2015","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.jiph.2026.103379_bib131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2004-818938","article-title":"Joanna Thompson Coon EE. Andrographis paniculatain the Treatment of Upper Respiratory Tract Infections: A Systematic Review of Safety and Efficacy","volume":"70","year":"2004","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib132","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib133","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":"Cidofovir-induced end-stage renal failure","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020278","article-title":"Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects","volume":"11","author":"Imran","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","article-title":"Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"145","author":"Chang","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/v15010103","article-title":"Smallpox, Monkeypox and Other Human Orthopoxvirus Infections","volume":"15","author":"Shchelkunova","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2026.103379_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106971","article-title":"FDA's authorized \u201cJYNNEOS\u201d vaccine for counteracting monkeypox global public health emergency; an update \u2013 Correspondence","volume":"107","author":"Sah","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.jiph.2026.103379_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1149909","article-title":"Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis","volume":"14","author":"Shamim","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiph.2026.103379_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106960","article-title":"Challenges in the treatment and prevention of monkeypox infection; A comprehensive review","volume":"245","author":"Nyame","year":"2023","journal-title":"Acta Trop"},{"issue":"0","key":"10.1016\/j.jiph.2026.103379_bib140","first-page":"0","article-title":"Drug Delivery Systems Designed to Maximize the Therapeutic Efficacy of Herbal Medication: A Review Article","volume":"0","author":"S. R. Khafaga","year":"2023","journal-title":"Egypt J Chem"},{"issue":"05","key":"10.1016\/j.jiph.2026.103379_bib141","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0043-102949","article-title":"Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs","volume":"83","author":"Bilia","year":"2017","journal-title":"Planta Med"},{"issue":"19","key":"10.1016\/j.jiph.2026.103379_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195905","article-title":"Controlled Drug Delivery Systems: Current Status and Future Directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/v15020568","article-title":"Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases","volume":"15","author":"Hajjo","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jiph.2026.103379_bib144","article-title":"Mpox (formerly monkeypox): pathogenesis, prevention and treatment","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.jiph.2026.103379_bib145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jiph.2026.103379_bib146","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2223669","article-title":"Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus","volume":"12","author":"Li","year":"2023","journal-title":"Emerg Microbes & Infect"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:08:16Z","timestamp":1792134496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":146,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1876034126002510"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103379","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monkeypox as an emerging public health concern: Evidence gaps, translational barriers, transmission, risk factors, and prevention strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103379"}}